Help us: Donate
Follow us on:
×

Menu

Back

Repair Biotechnologies

Organization Description

Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), a first in class approach to therapy aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

Team

Reason

Repair Biotechnologies - CEO

Bill Cherman

Repair Biotechnologies